Blue Venture Fund (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Chicago
The Blue Venture Fund is an American corporate venture fund program to which thirty-five BCBS entities have committed over $800 million across four Funds
Average round investment:41.18M USD
Average number per year:1.0
Distribution:
2025 (1)2022 (1)2021 (1)
Portfolio companies:
Ultromics
Perspectum
Ultromics
Perspectum
Mostly invests in:
United Kingdom (3)
Health services (3)
United Kingdom (3)
Health services (3)
3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Blue Venture Fund
| Name | Criteria | |
|---|---|---|
![]() |
Cantor Fitzgerald Private Clients
92%
|
|
![]() |
Inovia Capital
92%
|
|
![]() |
Tom Chapman
92%
|
|
![]() |
Perscitus LLP
92%
|
|
![]() |
Wheatsheaf Group
91%
|
|
![]() |
Intel Capital
91%
|
|
![]() |
Leaps by Bayer
91%
|
|
![]() |
415 Capital
90%
|
|
![]() |
Optum Ventures
90%
|
|
![]() |
Famille C Venture
90%
|
|





Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Italy
Portugal
Spain